OBJECTIVE: To study the prognostic value of antibodies to cyclic citrullinated peptide (anti-CCP)
and rheumatoid factor (RF), alone and in combination, in patients with very early …

Objective The first 3 months after symptom onset represent an important therapeutic window
for rheumatoid arthritis (RA). This study investigates the extent and causes of delay in …

Objectives. To study the delay from the time of symptom onset to assessment by a Rheumatologist
in patients with rheumatoid arthritis (RA) and to determine the contributions of patient …

Synovial leukocyte apoptosis is inhibited in established rheumatoid arthritis (RA). In contrast,
high levels of leukocyte apoptosis are seen in self-limiting crystal arthritis. The phase in the …

Objective. To assess whether patients with RA and SLE who are of South Asian origin have
different beliefs about medicines in general, and about DMARDs in particular, compared …

Background Rheumatoid arthritis (RA) is a common chronic inflammatory disease causing
joint damage, disability, and reduced life expectancy. Highly effective drugs are now available …

Background Prevalence of diabetes and cardiovascular (CVD) disease amongst UK South
Asians is higher than in the general population. Non-adherence to medicines may lead to …

Objective. Effective treatment can only be given during the early stages of RA if patients are
seen early. However, many patients delay for prolonged periods before seeking medical …

Objective. Delay in assessment by rheumatologists of patients with new-onset RA is an
important deter minant of delay in treatment initiation. The influence of ethnicity on delay in …

Treating patients with rheumatoid arthritis (RA) within three months of symptom onset leads
to significantly improved outcomes. However, many people delay seeking medical attention. …